Recently, the effects of ROCK inhibitors on p-Tau have also been studied using a human neuroblastoma cell line (M1C) expressing wild-type Tau protein, primary mouse neurons, and a mouse model of Tauopathy (rTg4510 line). The gene discussed is MAPT; the disease is tauopathy.